ZA200204873B - Solid state forms of 5-[[6-[(2-Flourophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-Thiazolidinedione. - Google Patents

Solid state forms of 5-[[6-[(2-Flourophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-Thiazolidinedione.

Info

Publication number
ZA200204873B
ZA200204873B ZA200204873A ZA200204873A ZA200204873B ZA 200204873 B ZA200204873 B ZA 200204873B ZA 200204873 A ZA200204873 A ZA 200204873A ZA 200204873 A ZA200204873 A ZA 200204873A ZA 200204873 B ZA200204873 B ZA 200204873B
Authority
ZA
South Africa
Prior art keywords
flourophenyl
thiazolidinedione
naphthalenyl
methoxy
methyl
Prior art date
Application number
ZA200204873A
Other languages
English (en)
Inventor
Mark C Andries
Stephen R Bryn
Ann W Newman
Catherine Russel
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of ZA200204873B publication Critical patent/ZA200204873B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA200204873A 1999-11-19 2002-06-18 Solid state forms of 5-[[6-[(2-Flourophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-Thiazolidinedione. ZA200204873B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16651599P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
ZA200204873B true ZA200204873B (en) 2003-11-26

Family

ID=22603643

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204873A ZA200204873B (en) 1999-11-19 2002-06-18 Solid state forms of 5-[[6-[(2-Flourophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-Thiazolidinedione.

Country Status (16)

Country Link
EP (1) EP1235817A1 (xx)
JP (1) JP2003514807A (xx)
CN (1) CN1423639A (xx)
AR (1) AR029409A1 (xx)
AU (1) AU1776701A (xx)
BG (1) BG106692A (xx)
BR (1) BR0015702A (xx)
CA (1) CA2391429A1 (xx)
HU (1) HUP0203280A3 (xx)
IL (1) IL149593A0 (xx)
MX (1) MXPA02005008A (xx)
NO (1) NO20022329L (xx)
RU (1) RU2002113123A (xx)
WO (1) WO2001036401A1 (xx)
YU (1) YU35602A (xx)
ZA (1) ZA200204873B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055774A (zh) * 2013-03-22 2014-09-24 天津药物研究院 一种稳定的非晶态盐酸吡格列酮复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
JP4023697B2 (ja) * 1996-11-14 2007-12-19 三菱化学株式会社 ナフタレン誘導体の製造方法
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
MXPA02005008A (es) 2003-10-14
CA2391429A1 (en) 2001-05-25
BR0015702A (pt) 2002-07-16
HUP0203280A3 (en) 2003-07-28
IL149593A0 (en) 2002-11-10
EP1235817A1 (en) 2002-09-04
HUP0203280A2 (hu) 2003-01-28
CN1423639A (zh) 2003-06-11
AR029409A1 (es) 2003-06-25
WO2001036401A1 (en) 2001-05-25
NO20022329L (no) 2002-07-09
RU2002113123A (ru) 2004-01-20
YU35602A (sh) 2006-05-25
JP2003514807A (ja) 2003-04-22
NO20022329D0 (no) 2002-05-15
AU1776701A (en) 2001-05-30
BG106692A (bg) 2003-03-31

Similar Documents

Publication Publication Date Title
ZA200109735B (en) Substituted heterocycle fused gamma-carbolines.
HK1046139A1 (en) Glucokinase activators.
MXPA03006498A (es) Entrecara termica de cambio de fase, de liberacion limpia.
HK1069997A1 (en) 2-amino-4,5-trisubstituted thiazolyl derivatives 2-4,5-
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
AU2001262150A1 (en) 2-(nitrogen-heterocyclic)pyrimidone derivatives
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
ZA9811925B (en) Thiazole derivatives.
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
ZA200202185B (en) 4-hydroxybiphenyl hydrazide derivatives.
AU2001243566A1 (en) Architecture for very high-speed decision feedback sequence estimation
GB2363691B (en) Media independent interface between ieee 802.3 (ethernet) based physical layer devices
AU2001258841A1 (en) Heterocyclic compounds
MXPA02001117A (es) Compuestos heterociclicos inhibidores de angiogenesis.
ZA200204873B (en) Solid state forms of 5-[[6-[(2-Flourophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-Thiazolidinedione.
HUP0104139A3 (en) Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
MXPA03001550A (es) Proceso catalitico para la preparacion de derivados de tiazol.
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
HUP0103517A3 (en) Improved process for the preparation of thiazolidine-2,4-dione derivatives
MXPA01011285A (es) Derivados de tio-oxindol.
AU2001236048A1 (en) Oxygen-containing heterocyclic compounds
AU4300900A (en) Carriage for transporting skis
ZA99407B (en) Extended release tiagabine formulations with reduced side-effects.
HUP0300723A3 (en) Process for the preparation of 5-[(4-chlorophenyl)-methyl]-2,2-dimethylcylopentanone